• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

3.700 -0.310 (-7.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA
July 07, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
July 06, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Is This Beaten-Down Stock a Millionaire Maker? ↗
July 06, 2025
Via The Motley Fool
News headline image
Deadline is July 14, 2025 to Lead in Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA) - Contact Kaplan Fox
July 03, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Deadline is July 14, 2025 to Lead in Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA) - Contact Kaplan Fox
July 03, 2025
Via TheNewswire.com
Topics Lawsuit
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
July 03, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
July 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against IOVA
July 03, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
July 14, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against IOVA
July 03, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) Seeking Recovery for Investors - Contact Levi & Korsinsky
July 02, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) Seeking Recovery for Investors - Contact Levi &amp; Korsinsky
July 02, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
July 02, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IOVA
July 01, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Levi &amp; Korsinsky Notifies Iovance Biotherapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IOVA
July 01, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
IOVA CLASS REMINDER: Iovance Biotherapeutics is Being Sued for Securities Fraud - Contact BFA Law by July 14 if You Suffered Losses
July 01, 2025
Via ACCESS Newswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
July 01, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages Investors to Contact the Firm
June 30, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
IOVA DEADLINE REMINDER: Iovance Biotherapeutics Investors are Reminded of the Approaching July 14 Legal Deadline -- Contact BFA Law if You Lost Money
June 30, 2025
Via ACCESS Newswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
June 30, 2025
Via ACCESS Newswire
News headline image
July 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against IOVA
June 30, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
July 14, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against IOVA
June 30, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
June 29, 2025
Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value 
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA
June 28, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
June 28, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Lead Plaintiff Deadline is July 14, 2025 for Investors of Iovance Biotherapeutics, Inc. (IOVA) - Contact Kaplan Fox
June 28, 2025
Via TheNewswire.com
Topics Lawsuit
News headline image
Lead Plaintiff Deadline is July 14, 2025 for Investors of Iovance Biotherapeutics, Inc. (IOVA) - Contact Kaplan Fox
June 28, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Why Iovance Biotherapeutics Stock Dove by Almost 15% This Week ↗
June 27, 2025
Via The Motley Fool
News headline image
IOVA DEADLINE NOTICE: Iovance Biotherapeutics Investors that Suffered Losses are Notified of the July 14 Class Action Deadline -- Contact BFA Law
June 27, 2025
Via ACCESS Newswire
News headline image
Iovance Biotherapeutics, Inc. Class Action: Levi &amp; Korsinsky Reminds Iovance Biotherapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 14, 2025 - IOVA
June 27, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Iovance Biotherapeutics, Inc. Class Action: Levi & Korsinsky Reminds Iovance Biotherapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 14, 2025 - IOVA
June 27, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure - Hagens Berman
June 26, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap